Who we are

Dr. Jeffrey Kasher
Back to team

Dr. Jeffrey Kasher

Advisor

Jeffrey Kasher is a known pharmaceutical development change expert with 28 years of experience at Eli Lilly. He is passionate for improving outcomes, bringing patients and research sites into the development process, and dramatically decreasing time to market. His expertise includes novel product development from bench through market launch, research and clinical trial leadership, innovation center start up as well as new industry paradigm creation.

Jeff is President of Patients Can’t Wait, Chairman of Advisory Board for DrugDev as well as member of Advisory Board of TrialReach and GoBalto. He sits on the DPharm Europe steering committee and faculty, and is a member of Linking Leaders. In 2013 CenterWatch Jeff was named one of the “20 Innovators Changing the Face of the Clinical Trials Industry.” He received a B.S. in Chemistry from Franklin & Marshall College, a Ph.D. in Pharmacology from the State University of New York, and a Post-Doctoral Fellowship in Physiology at Yale University School of Medicine.

Angle RightHome IconClock IconLinkedInMailTwitterDownload IconLinkedIn iconMail IconTwitter IconInfo IconMap MarkerMenu IconSmall Heart HoverSmall HeartX